Haoqiang Zhang
Hefei, 230001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
A multi-omics atlas of multisystem complications in type 2 diabetes reveals molecular signatures and improves risk prediction.
Journal: Metabolism: clinical and experimental
Published: January 15, 2026
Astrocytic SCAP deletion ameliorates diabetes-associated cognitive impairment by suppressing microglial neuroinflammation and lipid droplet accumulation via the LCN2-24p3R-mTOR axis.
Journal: Cell death & disease
Published: September 01, 2025
Integrative functional genomics and fine-mapping identify regulatory mechanisms of multivariate obesity GWAS and its cardiometabolic implications.
Journal: Metabolism: clinical and experimental
Published: July 30, 2025
Cholesterol-driven pathological astrocytic responses in diabetes-associated cognitive impairment through astrocytic SCAP accumulation and NF-κB-C3 signaling modulation.
Journal: Experimental & molecular medicine
Published: December 02, 2024
Heat shock protein 90α may serve as a biomarker for mild cognitive impairment in type 2 diabetes mellitus patients without diabetic nephropathy.
Journal: Frontiers in immunology
Published: October 25, 2024
The role of activated partial thrombin time in mediating the impact of poorly glycemic control on diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.
Journal: Frontiers in endocrinology
Published: September 24, 2024
Lower Free Triiodothyronine is a Risk Factor of Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: July 30, 2024
Interleukin-5: an indicator of mild cognitive impairment in patients with type 2 diabetes mellitus - a comprehensive investigation ranging from bioinformatics analysis to clinical research.
Journal: Journal of endocrinological investigation
Published: May 27, 2024
Peripheral blood heat shock protein 27 correlates with information processing speed and executive function, potentially serving as a marker for mild cognitive impairment in patients with type 2 diabetes mellitus.
Journal: Diabetology & metabolic syndrome
Published: February 12, 2024
Microglial SCAP deficiency protects against diabetes-associated cognitive impairment through inhibiting NLRP3 inflammasome-mediated neuroinflammation.
Journal: Brain, behavior, and immunity
Published: October 23, 2023
Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease.
Journal: Diabetology & metabolic syndrome
Published: September 20, 2023
Assessing the diagnostic utility of urinary albumin-to-creatinine ratio as a potential biomarker for diabetic peripheral neuropathy in type 2 diabetes mellitus patients.
Journal: Scientific reports
Published: September 05, 2023
Last Updated: 09/26/2026